CD4 and breast cancer: Comparably, ER-negative BC patients are primarily richer in regulatory T cells (Tregs), TAM2, and activated mast cells, while the cells associated with better prognosis such as CD8+T, CD4+T, B lymphocytes, and DCs are less abundant (56).